• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体内剂量依赖性癌基因诱导的衰老及其在乳腺肿瘤发生过程中的逃逸。

Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.

作者信息

Sarkisian Christopher J, Keister Blaine A, Stairs Douglas B, Boxer Robert B, Moody Susan E, Chodosh Lewis A

机构信息

Department of Cancer Biology, The Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6160, USA.

出版信息

Nat Cell Biol. 2007 May;9(5):493-505. doi: 10.1038/ncb1567. Epub 2007 Apr 22.

DOI:10.1038/ncb1567
PMID:17450133
Abstract

Activating Ras mutations can induce either proliferation or senescence depending on the cellular context. To determine whether Ras activation has context-dependent effects in the mammary gland, we generated doxycycline-inducible transgenic mice that permit Ras activation to be titrated. Low levels of Ras activation - similar to those found in non-transformed mouse tissues expressing endogenous oncogenic Kras2 - stimulate cellular proliferation and mammary epithelial hyperplasias. In contrast, high levels of Ras activation - similar to those found in tumours bearing endogenous Kras2 mutations - induce cellular senescence that is Ink4a-Arf- dependent and irreversible following Ras downregulation. Chronic low-level Ras induction results in tumour formation, but only after the spontaneous upregulation of activated Ras and evasion of senescence checkpoints. Thus, high-level, but not low-level, Ras activation activates tumour suppressor pathways and triggers an irreversible senescent growth arrest in vivo. We suggest a three-stage model for Ras-induced tumorigenesis consisting of an initial activating Ras mutation, overexpression of the activated Ras allele and, finally, evasion of p53-Ink4a-Arf-dependent senescence checkpoints.

摘要

激活型Ras突变可根据细胞环境诱导增殖或衰老。为了确定Ras激活在乳腺中是否具有环境依赖性作用,我们构建了强力霉素诱导型转基因小鼠,使Ras激活能够被滴定。低水平的Ras激活——类似于在表达内源性致癌Kras2的未转化小鼠组织中发现的水平——刺激细胞增殖和乳腺上皮增生。相比之下,高水平的Ras激活——类似于在携带内源性Kras2突变的肿瘤中发现的水平——诱导细胞衰老,这种衰老依赖Ink4a-Arf且在Ras下调后不可逆。慢性低水平Ras诱导会导致肿瘤形成,但只有在活化Ras自发上调并逃避衰老检查点之后才会发生。因此,高水平而非低水平的Ras激活会激活肿瘤抑制途径并在体内触发不可逆的衰老生长停滞。我们提出了一个Ras诱导肿瘤发生的三阶段模型,包括最初的激活型Ras突变、激活型Ras等位基因的过表达,以及最终逃避p53-Ink4a-Arf依赖性衰老检查点。

相似文献

1
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.体内剂量依赖性癌基因诱导的衰老及其在乳腺肿瘤发生过程中的逃逸。
Nat Cell Biol. 2007 May;9(5):493-505. doi: 10.1038/ncb1567. Epub 2007 Apr 22.
2
Oncogene-induced senescence as an initial barrier in lymphoma development.癌基因诱导的衰老作为淋巴瘤发展的初始屏障。
Nature. 2005 Aug 4;436(7051):660-5. doi: 10.1038/nature03841.
3
Transcriptional factor HBP1 targets P16(INK4A), upregulating its expression and consequently is involved in Ras-induced premature senescence.转录因子 HBP1 靶向 P16(INK4A),上调其表达,从而参与 Ras 诱导的过早衰老。
Oncogene. 2010 Sep 9;29(36):5083-94. doi: 10.1038/onc.2010.252. Epub 2010 Jun 28.
4
p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.p130Cas作为乳腺上皮细胞增殖、存活及HER2-neu癌基因依赖性乳腺肿瘤发生的新型调节因子。
Cancer Res. 2006 May 1;66(9):4672-80. doi: 10.1158/0008-5472.CAN-05-2909.
5
Cellular senescence induced by p53-ras cooperation is independent of p21waf1 in murine embryo fibroblasts.在小鼠胚胎成纤维细胞中,由p53-ras协同作用诱导的细胞衰老独立于p21waf1。
J Cell Biochem. 2004 Jun 1;92(3):514-24. doi: 10.1002/jcb.20079.
6
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression.在乳腺癌进展模型中,核因子-κB对于上皮-间质转化和转移至关重要。
J Clin Invest. 2004 Aug;114(4):569-81. doi: 10.1172/JCI21358.
7
Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.缺乏p21的小鼠成纤维细胞会发生衰老,并且对致癌性Ras诱导的转化具有抗性。
Oncogene. 1999 Sep 2;18(35):4974-82. doi: 10.1038/sj.onc.1202880.
8
Tumour biology: senescence in premalignant tumours.肿瘤生物学:癌前肿瘤中的细胞衰老
Nature. 2005 Aug 4;436(7051):642. doi: 10.1038/436642a.
9
The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.Ink4a/Arf在ErbB2乳腺肿瘤发生中的作用。
Cancer Res. 2003 Jun 15;63(12):3395-402.
10
Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.乙型肝炎病毒 X 蛋白通过 DNA 甲基化抑制 p16(INK4a)的表达来克服应激诱导的早衰。
Cancer Lett. 2010 Feb 28;288(2):226-35. doi: 10.1016/j.canlet.2009.07.007. Epub 2009 Aug 4.

引用本文的文献

1
Oncogene-Induced Senescence Transcriptomes Signify Premalignant Colorectal Adenomas.癌基因诱导的衰老转录组表明结直肠癌前腺瘤。
Curr Issues Mol Biol. 2025 Mar 25;47(4):221. doi: 10.3390/cimb47040221.
2
Molecular Regulation of SASP in Cellular Senescence: Therapeutic Implications and Translational Challenges.细胞衰老过程中衰老相关分泌表型(SASP)的分子调控:治疗意义与转化挑战
Cells. 2025 Jun 20;14(13):942. doi: 10.3390/cells14130942.
3
Elucidating Ras protein as a dual therapeutic target for inflammation and cancer: a review.阐明Ras蛋白作为炎症和癌症的双重治疗靶点:综述
Discov Oncol. 2025 Jun 7;16(1):1029. doi: 10.1007/s12672-025-02783-x.
4
Orthogonal resistance mechanisms of classical- and induced-proximity inhibitors.经典型和诱导型接近抑制剂的正交抗性机制。
bioRxiv. 2025 May 15:2025.05.10.652755. doi: 10.1101/2025.05.10.652755.
5
Deciphering the history of ERK activity from fixed-cell immunofluorescence measurements.从固定细胞免疫荧光测量中解读细胞外信号调节激酶(ERK)活性的历史。
Nat Commun. 2025 May 21;16(1):4721. doi: 10.1038/s41467-025-58348-7.
6
The rise of RAS: how gradual oncogene activation shapes the OIS spectrum.RAS的兴起:原癌基因的逐渐激活如何塑造衰老性生长停滞谱。
Genes Dev. 2025 Aug 1;39(15-16):936-947. doi: 10.1101/gad.352761.125.
7
Resolution of oncogene-induced senescence markers in HPV-infected cervical cancer tissue.人乳头瘤病毒(HPV)感染的宫颈癌组织中癌基因诱导的衰老标志物的消退
BMC Cancer. 2025 Jan 21;25(1):111. doi: 10.1186/s12885-025-13499-0.
8
The paradox of senescent-marker positive cancer cells: challenges and opportunities.衰老标志物阳性癌细胞的悖论:挑战与机遇
NPJ Aging. 2024 Sep 14;10(1):41. doi: 10.1038/s41514-024-00168-y.
9
Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?治疗诱导的细胞衰老:增强肿瘤消除或导致癌症耐药和复发?
Cells. 2024 Jul 30;13(15):1281. doi: 10.3390/cells13151281.
10
Titration of RAS alters senescent state and influences tumour initiation.RAS 滴定改变衰老状态并影响肿瘤起始。
Nature. 2024 Sep;633(8030):678-685. doi: 10.1038/s41586-024-07797-z. Epub 2024 Aug 7.